128 related articles for article (PubMed ID: 25432541)
1. Recurrent radiation necrosis in the brain following stereotactic radiosurgery.
Parker GM; Dunn IF; Ramkissoon SH; Eneman JD; Rabin MS; Arvold ND
Pract Radiat Oncol; 2015; 5(3):e151-e154. PubMed ID: 25432541
[No Abstract] [Full Text] [Related]
2. Inflammation Flare and Radiation Necrosis Around a Stereotactic Radiotherapy-Pretreated Brain Metastasis Site After Nivolumab Treatment.
Furuta H; Yoshida T; Natsume A; Hida T; Yatabe Y
J Thorac Oncol; 2018 Dec; 13(12):1975-1978. PubMed ID: 30017830
[No Abstract] [Full Text] [Related]
3. Immunotherapy and Symptomatic Radiation Necrosis in Patients With Brain Metastases Treated With Stereotactic Radiation.
Martin AM; Cagney DN; Catalano PJ; Alexander BM; Redig AJ; Schoenfeld JD; Aizer AA
JAMA Oncol; 2018 Aug; 4(8):1123-1124. PubMed ID: 29327059
[TBL] [Abstract][Full Text] [Related]
4. Association Between Radiation Necrosis and Tumor Biology After Stereotactic Radiosurgery for Brain Metastasis.
Miller JA; Bennett EE; Xiao R; Kotecha R; Chao ST; Vogelbaum MA; Barnett GH; Angelov L; Murphy ES; Yu JS; Ahluwalia MS; Suh JH; Mohammadi AM
Int J Radiat Oncol Biol Phys; 2016 Dec; 96(5):1060-1069. PubMed ID: 27742540
[TBL] [Abstract][Full Text] [Related]
5. Impact of pemetrexed on intracranial disease control and radiation necrosis in patients with brain metastases from non-small cell lung cancer receiving stereotactic radiation.
Cagney DN; Martin AM; Catalano PJ; Reitman ZJ; Mezochow GA; Lee EQ; Wen PY; Weiss SE; Brown PD; Ahluwalia MS; Arvold ND; Tanguturi SK; Haas-Kogan DA; Alexander BM; Redig AJ; Aizer AA
Radiother Oncol; 2018 Mar; 126(3):511-518. PubMed ID: 29398153
[TBL] [Abstract][Full Text] [Related]
6. [The boundaries of curation].
Debus J; Eberhardt W; Hoffmann H; Passlick B; Rübe C; Thomas M
Onkologie; 2010; 33 Suppl 5():12-20. PubMed ID: 20523102
[TBL] [Abstract][Full Text] [Related]
7. Post-stereotactic radiosurgery brain metastases: a review.
Fabiano AJ; Qiu J
J Neurosurg Sci; 2015 Jun; 59(2):157-67. PubMed ID: 25600555
[TBL] [Abstract][Full Text] [Related]
8. Stereotactic radiosurgery for the management of brain metastases.
Suh JH
N Engl J Med; 2010 Mar; 362(12):1119-27. PubMed ID: 20335588
[No Abstract] [Full Text] [Related]
9. Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery.
Ferrarese F; Baggio V; Zorat PL; Fiore D
Ann Oncol; 2006 Mar; 17 Suppl 2():ii71-72. PubMed ID: 16608990
[No Abstract] [Full Text] [Related]
10. Radiosurgery for brain metastases and cerebral edema.
Gazit I; Har-Nof S; Cohen ZR; Zibly Z; Nissim U; Spiegelmann R
J Clin Neurosci; 2015 Mar; 22(3):535-8. PubMed ID: 25533053
[TBL] [Abstract][Full Text] [Related]
11. Differentiating radiation necrosis from tumor progression in brain metastases treated with stereotactic radiotherapy: utility of intravoxel incoherent motion perfusion MRI and correlation with histopathology.
Detsky JS; Keith J; Conklin J; Symons S; Myrehaug S; Sahgal A; Heyn CC; Soliman H
J Neurooncol; 2017 Sep; 134(2):433-441. PubMed ID: 28674974
[TBL] [Abstract][Full Text] [Related]
12. [Contribution of PET in the follow-up of cerebral metastases in non-small cell lung cancer. A clinical case valuation].
Ferrer Rebolleda J; Ortega de los Mártires F; Santos Cores J; Menéndez López A; Arribas Alpuente L; Almenar Medina S
Rev Esp Med Nucl; 2006; 25(2):107-12. PubMed ID: 16759617
[TBL] [Abstract][Full Text] [Related]
13. Can standard magnetic resonance imaging reliably distinguish recurrent tumor from radiation necrosis after radiosurgery for brain metastases? A radiographic-pathological study.
Dequesada IM; Quisling RG; Yachnis A; Friedman WA
Neurosurgery; 2008 Nov; 63(5):898-903; discussion 904. PubMed ID: 19005380
[TBL] [Abstract][Full Text] [Related]
14. Multidose stereotactic radiosurgery (9 Gy × 3) of the postoperative resection cavity for treatment of large brain metastases.
Minniti G; Esposito V; Clarke E; Scaringi C; Lanzetta G; Salvati M; Raco A; Bozzao A; Maurizi Enrici R
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):623-9. PubMed ID: 23683828
[TBL] [Abstract][Full Text] [Related]
15. Onartuzumab ineffective in non-small-cell lung cancer.
Brower V
Lancet Oncol; 2017 Feb; 18(2):e66. PubMed ID: 28017663
[No Abstract] [Full Text] [Related]
16. Phase I/II study of intermitted erlotinib in combination with docetaxel in patients with recurrent non-small cell lung cancer (WJOG4708L).
Kimura T; Kawaguchi T; Chiba Y; Yoshioka H; Watanabe K; Kijima T; Kogure Y; Oguri T; Yoshimura N; Niwa T; Kasai T; Hayashi H; Ono A; Asai K; Tanaka H; Yano S; Yamamoto N; Nakanishi Y; Nakagawa K
Jpn J Clin Oncol; 2019 Oct; 49(10):947-955. PubMed ID: 31242302
[TBL] [Abstract][Full Text] [Related]
17. Stereotactic radiotherapy following surgery for brain metastasis: Predictive factors for local control and radionecrosis.
Doré M; Martin S; Delpon G; Clément K; Campion L; Thillays F
Cancer Radiother; 2017 Feb; 21(1):4-9. PubMed ID: 27955888
[TBL] [Abstract][Full Text] [Related]
18. Symptomatic radiation necrosis in brain metastasis patients treated with stereotactic radiosurgery and immunotherapy.
Weingarten N; Kruser TJ; Bloch O
Clin Neurol Neurosurg; 2019 Apr; 179():14-18. PubMed ID: 30784894
[TBL] [Abstract][Full Text] [Related]
19. Single-Fraction Stereotactic Radiosurgery (SRS) Alone Versus Surgical Resection and SRS for Large Brain Metastases: A Multi-institutional Analysis.
Prabhu RS; Press RH; Patel KR; Boselli DM; Symanowski JT; Lankford SP; McCammon RJ; Moeller BJ; Heinzerling JH; Fasola CE; Asher AL; Sumrall AL; Buchwald ZS; Curran WJ; Shu HG; Crocker I; Burri SH
Int J Radiat Oncol Biol Phys; 2017 Oct; 99(2):459-467. PubMed ID: 28871997
[TBL] [Abstract][Full Text] [Related]
20. Pulsatile Erlotinib in EGFR-Positive Non-Small-Cell Lung Cancer Patients With Leptomeningeal and Brain Metastases: Review of the Literature.
How J; Mann J; Laczniak AN; Baggstrom MQ
Clin Lung Cancer; 2017 Jul; 18(4):354-363. PubMed ID: 28245967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
